CareDx Starts Enrollment in MAPLE, a Multi-modal, Multi-center, Prospective Study of LiverCareStudy to demonstrate utility of LiverCare post-transplant surveillance for liver transplant recipients - read this article along with other careers information, tips and advice on BioSpace
Published: Apr 05, 2021
SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE)
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced its presence at the National Kidney Foundation’s 2021 Spring Clinical Meetings, which will take place virtually, April 6-10, 2021.
As a leader in non-invasive approaches for assessing the health of transplanted kidneys, CareDx will host
“Next Generation Care for Kidney Transplant Patients,” a 30-minute exhibitor showcase on April 6th from 11:00-11:30 a.m. Eastern Time.
Program details:
Innovations in Kidney Transplant Care, with Dr. Christopher Boshkos, Medical Director of Kidney Transplantation at CareDx
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
CareDx Showcases Cellular Transplantation and Therapy Portfolio at TCT
CareDx, Inc.February 5, 2021 GMT
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced plans to showcase the CareDx Cellular Transplant Therapies portfolio at the Transplantation and Cellular Therapy Meeting (TCT) February 8-12, 2021.
CareDx will have four abstracts presented in poster presentations. One poster will be presented in partnership with Atara Biotherapeutics on the potential use of AlloCell for standardized pharmacokinetic assessment in a clinical trial. The other posters will highlight data on AlloHeme and AlloSeq HCT for chimerism and recurrence surveil
CareDx Constantly Revolutionizing Personalized Care for Transplant Recipients
Share Article
In the newest episode of Tomorrow’s World Today, field reporter Darieth Chisolm heads to CareDx headquarters where she learns how they focus on the transplant journey of each individual recipient to make sure all transplant recipients receive personalized care specifically for their transplanted organ. CareDx is 100% dedicated to transplant patient care.We are at an exciting inflection point as we build comprehensive solutions to enable direct patient engagement and personalized care,” said Peter Maag, Executive Chairman at CareDx. PITTSBURGH (PRWEB) December 15, 2020 One of the biggest worries in organ transplantation is how well the transplant recipient’s body will receive the organ that is donated. The first successful kidney transplant happened back in 1954 when the recipient’s donor was his identical twin. B